Diamonds and Dogs


JNJ (JNJ) inching closer to approval of their COVID-19 vaccine. JNJ is up 2% as the FDA released a lengthy analysis supporting their Covid-19 vaccine. Final approval may come soon. The downside is JNJ only has 4 million doses of their vaccine ready to go with another 20 million by the end of March.

Not hip to be Square (SQ). The digital payment company is down 7% after reporting earnings. The company easily beat as sales rose 139% to $3.03 billion. In a new trend, Square bought $170 million in Bitcoin which represents about 5% of Square's total cash position. Investors seem to be focused on subscription and services growth that slowed in the fourth quarter.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.